Stay updated with breaking news from Optimal Balance Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Restylane VOLYME is designed for contouring and volumization of the mid-face region to support patients in achieving a youthful, revitalized look The complementary Shape Up Holistic Individualized
Galderma SWXGALD announced today the launch of its hyaluronic acid injectable filler Restylane VOLYME in China.
The unsurpassed NASHA technology, which is still used today as the benchmark for fillers, was pioneered by Galderma Galderma, the world's largest independent dermatology company, today marks the 25th
Galderma Receives FDA Approval for Restylane® Defyne for Chin Augmentation Represents second approved indication for Restylane Defyne in U.S.; expands Galderma Aesthetics' growing Restylane product portfolio News provided by Share this article Share this article FORT WORTH, Texas, Feb. 2, 2021 /PRNewswire/ -- Galderma announces that the U.S. Food and Drug Administration (FDA) has approved Restylane ® Defyne for the augmentation and correction of mild to moderate chin retrusion for adults over the age of 21. 1 In 2020 alone, online searches for chin enhancement increased by 185 percent, rei...